LOS ANGELES, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sona Nanotech, Inc. ("Sona" or the "Company") (OTC: SNANF) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The investigation focuses on whether Sona issued misleading and/or false statements and/or failed to disclose information pertinent to investors. On October 29, 2020 it was announced by Sona that its request for an emergency use authorization to market its rapid COVID-19 antigen test in the United States was denied by the FDA. On the same day, Sona’s shares fell 48%. On November 25, 2020, the withdrawal of “an Interim Order authorization from Health Canada for the marketing of its rapid, COVID-19 antigen test in order to obtain more clinical data to augment its submission” was announced by Sona. Shares of Sona fell by more than 67% on the same day based on this news.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising